SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2015 |
Dec. 31, 2014 |
Dec. 31, 2013 |
|
Goodwill. | |||
Goodwill | $ 482 | $ 479 | $ 461 |
Percentage of total goodwill, emissions solutions and filtration | 80.00% | ||
Research and Development | |||
Research and development expenses, net of contract reimbursements | $ 718 | 737 | 700 |
Research and Development Arrangement, Contract to Perform for Others, Compensation Earned | 98 | 121 | $ 76 |
U.S. Plans | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |||
Fair Value of Plan Assets Measured on Recurring Basis | 1,094 | 1,186 | |
Non-U.S. Plans | |||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |||
Fair Value of Plan Assets Measured on Recurring Basis | $ 514 | $ 497 |
X | ||||||||||
- Definition Represents assets valued based on their respective net asset value (or its equivalent), as an alternative to estimate fair value due to the absence of readily available market prices. Excludes plan assets and liabilities not measured at fair value. No definition available.
|
X | ||||||||||
- Definition This element represents the percentage of total goodwill as of the balance sheet date. No definition available.
|
X | ||||||||||
- Definition Research and development costs, excluding engineering, incurred for product improvement, innovation and cost reductions. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|